MedTech News
Medtronic, Recor Medical score renal denervation reimbursement wins
Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation (RDN) technologies.
FDA approves IDE for Akura Medical’s thrombectomy system
Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE).
NeurAxis wins expanded FDA clearance for non-implanted neurostim for pain relief
NeurAxis (NYSE:NRXS) announced today that the FDA granted an expanded 510(k) clearance for its IB-Stim non-implanted nerve stimulator.
COBRA-OS device receives special mention in TIME’s Best Inventions of 2024
Front Line Medical Technologies Inc, a leader in medical devices for emergency and trauma care, has announced that its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System) has been specially recognised in TIME’s Best Inventions of 2024.
Sense Neuro Diagnostics Awarded $2 Million Contract to Advance Brain Hemorrhage Detection Technology for Traumatic Brain Injury (TBI)
CINCINNATI, Nov. 4, 2024 /PRNewswire/ — Sense Neuro Diagnostics, a leader in developing technology for the diagnosis and monitoring of brain injuries, today announced it has been awarded a $2 million contract by the Department of Defense (DoD).
SeeMedX Files 510(k) with FDA for Innovative Cardiac Monitoring System to Transform Heart Failure Care
LAS VEGAS, Nov. 4, 2024 /PRNewswire/ — SeeMedX Inc. (“SeeMedX”) today announced the submission of its 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its innovative, non-invasive cardiac monitoring device, designed to allow medical professionals to have real-time insights into cardiac performance and fluid status
FDA clears Quanta home hemodialysis system
Quanta Dialysis Technologies announced today that it received FDA 510(k) clearance for the use of its dialysis system in the home.
R3 Vascular wins FDA IDE for drug-eluting scaffold
R3 Vascular announced today that the FDA granted investigational device exemption (IDE) to evaluate its Magnitude drug-eluting bioresorbable scaffold.